Recent Finacing
Recent Raise
Bone Therapeutics develops autologous and allogeneic osteoblastic cell therapies (PREOB, ALLOB) for fracture repair, osteonecrosis and osteoporosis, operating GMP manufacturing, preclinical R&D, and clinical-stage programs.